We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression.
- Authors
Umi M Abd Hamid; Louise Royle; Radka Saldova; Catherine M Radcliffe; David J Harvey; Sarah J Storr; Maria Pardo; Robin Antrobus; Caroline J Chapman; Nicole Zitzmann; John F Robertson; Raymond A Dwek; Pauline M Rudd
- Abstract
Aberrant glycosylation on glycoproteins that are either presented on the surface or secreted by cancer cells is a potential source of disease biomarkers and provides insights into disease pathogenesis. N-Glycans of the total serum glycoproteins from advanced breast cancer patients and healthy individuals were sequenced by HPLC with fluorescence detection coupled with exoglycosidase digestions and mass spectrometry. We observed a significant increase in a trisialylated triantennary glycan containing α1,3-linked fucose which forms part of the sialyl Lewis x epitope. Following digestion of the total glycan pool with a combination of sialidase and β-galactosidase, we segregated and quantified a digestion product, a monogalactosylated triantennary structure containing α1,3-linked fucose. We compared breast cancer patients and controls and detected a 2-fold increase in this glycan marker in patients. In 10 patients monitored longitudinally, we showed a positive correlation between this glycan marker and disease progression and also demonstrated its potential as a better indicator of metastasis compared to the currently used biomarkers, CA 15-3 and carcinoembryonic antigen (CEA). A pilot glycoproteomic study of advanced breast cancer serum highlighted acute-phase proteins α1-acid glycoprotein, α1-antichymotrypsin, and haptoglobin β-chain as contributors to the increase in the glycan marker which, when quantified from each of these proteins, marked the onset of metastasis in advance of the CA 15-3 marker. These preliminary findings suggest that specific glycans and glycoforms of proteins may be candidates for improved markers in the monitoring of breast cancer progression.
- Subjects
CANCER patients; RECREATION for cancer patients; BLOOD plasma; BLOOD; SERUM
- Publication
Glycobiology, 2008, Vol 18, Issue 12, p1105
- ISSN
0959-6658
- Publication type
Article
- DOI
10.1093/glycob/cwn095